KraneShares SSE STAR Market 50 Index ETF (KSTR)

China established the STAR Market (Science and Technology Innovation Board) on the Shanghai Stock Exchange in 2019 to nurture homegrown technology and innovation companies. The board functions as China’s answer to the NASDAQ — a venue for younger, growth-oriented firms in semiconductors, biotechnology, cloud computing, and advanced manufacturing that might not yet meet the profitability thresholds of China’s main stock exchange. By design, the STAR Market accelerated the pace of technology IPOs within China and gave these companies faster access to capital than they would have in earlier eras.

The KSTR fund tracks the STAR 50 Index, which contains the 50 largest companies on this board, selected by market capitalization and liquidity. These are the flagship names: Cambricon (which designs AI chips), semiconductor equipment makers, biotech firms working on cancer therapies and regenerative medicine, and internet-connected cloud platforms. The geographic lens is crucial here. While the companies are incorporated and listed in Shanghai, many derive revenue from across China and overseas. Their sectors — semiconductors, medical devices, software — are globally competitive. The index weights holdings by free-float market cap, capping individual names at 8 percent to enforce some diversification.

An ETF holding Shanghai-listed securities is technically a cross-border product. KSTR accesses the STAR Market through Stock Connect programs that allow foreign investors to buy mainland Chinese stocks via Hong Kong intermediaries, removing the currency and liquidity barriers that once made mainland Chinese equities inaccessible to U.S. retail investors. This plumbing matters: trading can be smooth or subject to mainland regulatory closures; dividends flow through intermediaries and can face withholding taxes; and mainland China’s regulatory environment — government restrictions on particular sectors, delisting rules, and geopolitical tensions — filters through to share prices.

KSTR costs 0.89 percent annually, higher than a U.S. large-cap index ETF but reasonable given the cost of accessing mainland Chinese equities and the specialized nature of the index. The fund is small by ETF standards, with net assets under 300 million, which means liquidity is thinner than mega-cap funds. Bid-ask spreads can be wider, and large trades may face slippage.

Investors in KSTR are essentially betting on China’s technological prowess and innovation capacity, specifically among the companies the government has chosen to fast-track through the STAR Market. The upside is potential exposure to China’s next generation of dominant tech and biotech firms at an earlier stage than waiting for them to cross-list in the U.S. The risks are multiple: Chinese government policy can reshape any sector overnight; geopolitical tension with the United States can trigger restrictions on investment in Chinese tech; mainland volatility is occasionally acute; and the fund’s size means it may be hard to exit a large position without moving the market. Most critically, KSTR is denominated in Chinese renminbi but trades in U.S. dollars, so currency movements between the dollar and yuan add a layer of volatility separate from the underlying stocks’ performance.

For investors building a geographic and sectoral allocation strategy, KSTR offers pure China-tech exposure in a structure that is simpler than buying individual Chinese ADRs or trying to access Shanghai directly. To research, start with the fund’s prospectus and the STAR 50 Index methodology. Track the top holdings’ earnings and any Chinese regulatory developments. Watch cross-border capital flows and currency movements. Compare KSTR’s performance to other China tech funds like KWEB (which focuses on Chinese internet companies listed in Hong Kong) to understand how STAR Market technology differs from the more established, consumer-facing internet giants listed elsewhere.